Emerging HER2-Targeted TKIs in Lung Cancer: Navigating the New Frontier in Precision Oncology
June 23, 2025
View More
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
View More
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
View More
PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies
View More
Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer
View More
Medical Crossfire®: DLL3-Driven Innovations in Small Cell Lung Cancer – How Do Experts Apply Pivotal Advances to Practice?
View More
Top 10 Oncogenic Drivers in NSCLC for 2024: Where Are We and Where Are We Going?
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
PBM Transparency: Can It Be More Than a Buzzword?
July 1st 2025Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having complicated, sometimes hidden practices. The PBMs say they have responded with programs and policies that add transparency to what they do.
Prevention Could Cut Global Cancer Deaths in Half
June 30th 2025According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and breast cancer incidence due to increasing adoption of behaviors associated with economic development—such as tobacco use, poor nutrition and physical inactivity.
Medicare and Medicaid Patients With Opioid Addiction Less Likely to Receive Care, Study Shows
Patients addicted to opioids receive less mental health care if they are only covered by public insurance, compared with patients receiving care through alternate funding, according to a recent study published in Addiction Science & Clinical Practice.
After Pride: The Fight for LGBTQ+ Health Equity Isn’t Over
June 27th 2025As sweeping policy shifts and rising restrictions threaten LGBTQ+ health access, providers, payers and employers reflect on what’s at stake in Pride Month's end—and what it will take to protect affirming equitable care for the future.
Novo Nordisk and WeightWatchers Partnership, Plus $299 Wegovy Offer
Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their prescription filled through CenterWell Pharmacy, now associated with Novo Nordisk and WeightWatchers.
84% of Healthcare Leaders Worried About Business Conditions, Survey Says
This latest data is a change from previous survey answers, in which 71% of healthcare leaders expected improved profitability and 69% of leaders anticipated a rise in revenue in 2025, according to combined data from the Deloitte Center for Health Solutions.